Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Name: Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
License: Public Domain

Theravectys S.A.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv infection

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 195396
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.